1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Endometrial Hyperplasia Global Clinical Trials Review, H2, 2015

Endometrial Hyperplasia Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Endometrial Hyperplasia Global Clinical Trials Review, H2, 2015" provides an overview of Endometrial Hyperplasia clinical trials scenario. This report provides top line data relating to the clinical trials on Endometrial Hyperplasia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Endometrial Hyperplasia Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Endometrial Hyperplasia to Women's Health Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Endometrial Hyperplasia to Women's Health Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Endometrial Hyperplasia Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profile Snapshots 30
Appendix 48
Abbreviations 48
Definitions 48
Research Methodology 49
Secondary Research 49
About GlobalData 50
Contact Us 50
Disclaimer 50
Source 51

List of Tables
Endometrial Hyperplasia Therapeutics, Global, Clinical Trials by Region, 2015* 6
Endometrial Hyperplasia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Endometrial Hyperplasia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Endometrial Hyperplasia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Endometrial Hyperplasia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Endometrial Hyperplasia Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Endometrial Hyperplasia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Endometrial Hyperplasia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Endometrial Hyperplasia to Women's Health Clinical Trials, G7 Countries (%), 2015* 15
Endometrial Hyperplasia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Endometrial Hyperplasia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Endometrial Hyperplasia to Women's Health Clinical Trials, E7 Countries (%), 2015* 18
Endometrial Hyperplasia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Endometrial Hyperplasia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Endometrial Hyperplasia Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Endometrial Hyperplasia Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Endometrial Hyperplasia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Endometrial Hyperplasia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Endometrial Hyperplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Endometrial Hyperplasia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26
Endometrial Hyperplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Endometrial Hyperplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Endometrial Hyperplasia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29

List of Figures
Endometrial Hyperplasia Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Endometrial Hyperplasia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Endometrial Hyperplasia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Endometrial Hyperplasia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Endometrial Hyperplasia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Endometrial Hyperplasia Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Endometrial Hyperplasia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Endometrial Hyperplasia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Endometrial Hyperplasia to Women's Health Clinical Trials, G7 Countries (%), 2015* 15
Endometrial Hyperplasia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Endometrial Hyperplasia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Endometrial Hyperplasia to Women's Health Clinical Trials, E7 Countries (%), 2015* 18
Endometrial Hyperplasia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Endometrial Hyperplasia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Endometrial Hyperplasia Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Endometrial Hyperplasia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Endometrial Hyperplasia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Endometrial Hyperplasia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Endometrial Hyperplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Endometrial Hyperplasia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26
Endometrial Hyperplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Endometrial Hyperplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Endometrial Hyperplasia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
GlobalData Methodology 49

Companies mentioned
Pfizer Inc.
Bayer AG
TherapeuticsMD Inc.
Eli Lilly and Company

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Endometrial Cancer Market - Growth, Trends and Forecasts (2016 - 2021)

Global Endometrial Cancer Market - Growth, Trends and Forecasts (2016 - 2021)

  • $ 4250
  • Industry report
  • October 2016
  • by Mordor Intelligence LLP

The global endometrial cancer market is expected to grow at a CAGR of XX% during the forecast period 2016-2021. The market was valued at USD XX million in 2015 and is forecasted to reach USD XX million ...

Endometrial Cancer - Epidemiology Forecast To 2023

Endometrial Cancer - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Endometrial Cancer - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Endometrial Cancer in seven major markets (US, France, Germany, Italy, Spain, UK ...

 Endometrial Cancer-Pipeline Insights, 2017

Endometrial Cancer-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Endometrial Cancer-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Endometrial Cancer. The Delve ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.